B-cell engineering: A promising approach towards vaccine development for COVID-19
With the number of cases crossing six million (and more than three hundred and seventy thousand deaths) worldwide, there is a dire need of a vaccine (and repurposing of drugs) for SARS-CoV-2 disease (COVID-19). It can be argued that a vaccine may be the most efficient way to contain the spread of th...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12131
- Acceso en línea:
- https://doi.org/10.1016/j.mehy.2020.109948
http://hdl.handle.net/20.500.12010/12131
- Palabra clave:
- Vaccine
CRISPR
Genome editing
COVID-19
Coronavirus
B-cell
Antibody
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido